Canadian application, no grantCanada
Inhibition of src for treatment of reperfusion injury related to revascularization
CA 2500368 A1 · Owner: Losordo, Douglas W. · Inventors: Losordo, Douglas W.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods for treating preventing, or reducing , reperfusion injury or post-pump syndrome by administering an inhibitor of vascular endothelial growth factor-mediated vascular permeability.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 3, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 3, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 3, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledOctober 3, 2003
GrantedNo grant recorded
Term endedOctober 3, 2023
Patent numberCA 2500368 A1
Classification (IPC)A61K31/47
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.